ICD 10 CM C67.8 | Description & Clinical Information

ICD 10 C67.8 describes a type of cancerous growth of cells in the urinary bladder, specifically referring to malignant neoplasm that involves two or more adjacent sites of the bladder, with risk factors including overuse of certain medicines, smoking, exposure to certain chemicals at the workplace, drinking water containing arsenic, chronic bladder infections, congenital bladder defects, family history, and genetic factors.

Official Description Of C67.8

The ICD 10 CM book defines ICD 10 code C67.8 as:

When To Use C67.8

The diagnosis described by the ICD 10 CM C67.8 code pertains to patients who have been diagnosed with malignant neoplasms of overlapping sites of the bladder. These neoplasms refer to abnormal cell growth in the bladder tissue that is cancerous and can potentially spread to surrounding tissues.

Initially, patients with this diagnosis may experience painful and frequent urination, accompanied by hematuria or blood in the urine. As the cancer progresses, patients may also experience constant pain in the lower back, difficulty urinating, weakness, and weight loss. It is important to note that some patients may not experience any symptoms until the cancer has metastasized or spread to other parts of the body.

Healthcare providers diagnose malignant neoplasms using a variety of techniques, including conducting a medical history and physical examination. Laboratory tests are also essential in the diagnosis of this condition, including urinalysis, urine culture, specific urine tests to detect tumor markers, and biopsy of the bladder tissue. Imaging tests such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and intravenous pyelogram are also useful in identifying the extent of cancer spread and its impact on surrounding tissues.

Treatment for malignant neoplasms of the bladder depends on the stage and severity of the cancer. If the tumor is resectable, which means it can be removed through surgery, then surgical treatment is the best option. Transurethral resection of the urinary bladder tumor (TURBT), cystectomy or radical cystectomy may be required, followed by chemotherapy and/or radiotherapy. For patients with advanced neoplasms, chemotherapy and radiotherapy are used to alleviate symptoms and improve their quality of life.

The prognosis for patients with malignant neoplasms of the bladder depends on the stage and severity of the cancer. Early diagnosis and intervention can significantly improve survival rates, while advanced-stage bladder cancers have a poorer prognosis. It is crucial for individuals to seek medical attention immediately upon experiencing symptoms suggestive of bladder cancer, including painful urination, blood in urine, and lower back pain. Regular screening tests are also essential in early cancer detection and increasing the chance of recovery.

Overall, the ICD 10 CM C67.8 diagnosis code serves as an essential tool in the diagnosis and treatment of malignant neoplasms of the bladder. Timely diagnosis and intervention will help individuals regain their quality of life and increase their survival rates.